CurrentEndo
Get Weekly

Topic · page 24 of 35

Osteoporosis, bone & mineral

Osteoporosis in women and men, fracture risk and bone density, fragility fractures and their secondary prevention, bone drugs and treatment sequence; hyperparathyroidism and hypoparathyroidism, vitamin D, calcium and phosphate disorders, rare metabolic bone disease

Briefs 921–960 of 1,367 placed here, newest publication first

Briefs in Osteoporosis, bone & mineral

Newest publication first

  1. J Bone Miner Res

    Risk factors for hip and vertebral fractures in chronic kidney disease: the CRIC study

    Cohort study

  2. J Bone Miner Res

    Enhanced osteoporotic fracture prediction in postmenopausal women using Bayesian optimization of machine learning models with genetic risk score

    Diagnostic or prognostic study

  3. J Bone Miner Res

    Defining the key clinician skills and attributes for competency in managing patients with osteoporosis and fragility fractures

    Guideline or statement

  4. Osteoporos Int

    Return on investment of fracture liaison services: a systematic review and analysis

    Meta-analysis

  5. Osteoporos Int

    An investigation of the differential therapeutic effects of romosozumab on postmenopausal osteoporosis patients with or without rheumatoid arthritis complications: a case–control study

    Cohort study

  6. Osteoporos Int

    Vertebral fracture severity assessment on anteroposterior radiographs with a new semi-quantitative technique

    Diagnostic or prognostic study

  7. J Bone Miner Res

    Are associations between physical activity and bone mineral density in adults sex- and age-dependent? An analysis of the UK Biobank study

    Cross-sectional study

  8. J Bone Miner Res

    Equivalence trial of proposed denosumab biosimilar GP2411 and reference denosumab in postmenopausal osteoporosis: the ROSALIA study

    Randomized controlled trial

  9. J Bone Miner Res

    Decline in muscle strength and physical function after fracture in men – the prospective STRAMBO study

    Cohort study

  10. Osteoporos Int

    Fear-avoidant beliefs and behaviours after upper limb fracture in older people: a systematic review and meta-ethnography

    Meta-analysis

  11. Osteoporos Int

    Different bone health progression patterns and early-stage risk marker in glucocorticoid-treated ambulatory Duchenne muscular dystrophy

    Cohort study

  12. J Bone Miner Res

    Bone microarchitecture and strength assessment in adults with osteogenesis imperfecta using HR-pQCT: normative comparison and challenges

    Cross-sectional study

  13. Osteoporos Int

    Damaged bone microarchitecture by Trabecular Bone Score (TBS) and low appendicular muscle mass: main risk factors for vertebral and non-vertebral fractures in women with long-standing rheumatoid arthritis

    Cross-sectional study

  14. Osteoporos Int

    Average daily glucocorticoid dose, number of prescription days, and cumulative dose in the initial 90 days of glucocorticoid therapy are associated with subsequent hip and clinical vertebral fracture risk: a retrospective cohort study using a nationwide health insurance claims database in Japan

    Cohort study

  15. J Bone Miner Res

    Sedentary behavior does not predict low BMD nor fracture—population-based Canadian Multicentre Osteoporosis Study

    Cohort study

  16. Osteoporos Int

    Comparison of radiological and functional outcomes of conservative treatment with teriparatide and denosumab in thoracolumbar osteoporotic vertebral fracture

    Cohort study

  17. J Clin Endocrinol Metab

    Characterization and Predictors of Fractures Following Hematopoietic Stem Cell Transplantation

    Cohort study

  18. Osteoporos Int

    A new hip fracture risk index derived from FEA-computed proximal femur fracture loads and energies-to-failure

    Case-control study

  19. Osteoporos Int

    Selective estrogen receptor modulators (SERMs) with vitamin D composite agent can prevent fracture better than SERMs treatment: based on the National Health Claims Database 2017–2019

    Cohort study

  20. Osteoporos Int

    Opportunistically identifiable vertebral fractures on routine radiological imaging predict mortality: observational cohort study

    Cohort study

  21. Osteoporos Int

    A meta-analysis of previous falls and subsequent fracture risk in cohort studies

    Meta-analysis

  22. Clin Endocrinol (Oxf)

    Characteristics of bone mineral density in patients with functional hypothalamic amenorrhoea and its association with reproductive hormones and body composition

    Cross-sectional study

  23. Osteoporos Int

    A comprehensive meta-analysis of risk factors associated with osteosarcopenic obesity: a closer look at gender, lifestyle and comorbidities

    Meta-analysis

  24. Osteoporos Int

    Association between fatty liver index and controlled attenuation parameters as markers of metabolic dysfunction-associated fatty liver disease and bone mineral density: observational and two-sample Mendelian randomization studies

    Cohort study

  25. J Bone Miner Res

    Approaching virtual osteoid volume estimation and in-depth tissue characterization in patients with tumor-induced osteomalacia

    Cross-sectional study

  26. J Bone Miner Res

    Femoral neck width genetic risk score is a novel independent risk factor for hip fractures

    Diagnostic or prognostic study

  27. J Clin Endocrinol Metab

    Genetic Analysis, Phenotypic Spectrum and Functional Study of Rare Osteogenesis Imperfecta Caused by CRTAP Variants

    Mechanistic study

  28. Horm Res Paediatr

    Invited Mini Review Metabolic Bone Disease of Prematurity: Overview and Practice Recommendations

    Guideline or statement

  29. J Bone Miner Res

    Impaired muscle parameters in adults with mild to severe types of osteogenesis imperfecta: a cross-sectional study

    Cross-sectional study

  30. J Clin Endocrinol Metab

    Safety and Efficacy of Denosumab in Children With Osteogenesis Imperfecta—the First Prospective Comparative Study

    Randomized controlled trial

  31. J Clin Endocrinol Metab

    Bisphosphonate Use and Risk of Atypical Femoral Fractures: A Danish Case-Cohort Study With Blinded Radiographic Review

    Cohort study

  32. Osteoporos Int

    Trajectories of oral bisphosphonate use after hip fractures: a population-based cohort study

    Cohort study

  33. J Bone Miner Res

    Influence of vitamin D supplementation on bone mineral content, bone turnover markers, and fracture risk in South African schoolchildren: multicenter double-blind randomized placebo-controlled trial (ViDiKids)

    Secondary analysis

  34. Osteoporos Int

    Health-related quality of life in osteoporosis: a systematic review of measurement properties of the QUALEFFO-41

    Meta-analysis

  35. J Clin Endocrinol Metab

    Efficacy and Safety of Denosumab vs Zoledronic Acid in OI Adults: A Prospective, Open-Label, Randomized Study

    Randomized controlled trial

  36. Endocr Pract

    Predicting Osteoporotic Fracture in Patients With Early-Stage Diabetic Kidney Disease Using a Radiomic Model: A Longitudinal Cohort Study

    Cohort study

  37. Endocr Pract

    Primary Hyperparathyroidism: Assessment of the Effects of Parathyroidectomy Using Dual X-Ray Absorptiometry, Trabecular Bone Score, and Dual X-Ray Absorptiometry–Based Three-Dimensional Modeling

    Cohort study

  38. J Clin Endocrinol Metab

    Cardiometabolic Effects of Denosumab in Premenopausal Women With Breast Cancer Receiving Estradiol Suppression: RCT

    Secondary analysis

  39. J Bone Miner Res

    Rapid bone microarchitecture decline in older men with high bone turnover—the prospective STRAMBO study

    Cohort study

  40. J Bone Miner Res

    Prolonged bone health benefits for breast cancer patients following adjuvant bisphosphonate therapy: the BoHFAB study

    Secondary analysis

All 1,367 Briefs in ExploreShowing Briefs 921–960 of 1,367, newest first